Spermatid perinuclear RNA-binding protein promotes UBR5-mediated proteolysis of Dicer to accelerate triple-negative breast cancer progression
Cancer Letters · 2024-04 · 586 · 216672
DOI: 10.1016/j.canlet.2024.216672 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2024-04. Verfasst von Si-Yu Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, 200032, China. Hauptthemen laut MEDLINE: MicroRNAs, Triple Negative Breast Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Triple-negative breast cancer (TNBC) is the most lethal subtype of breast cancer with no targeted therapy. Spermatid perinuclear RNA binding protein (STRBP), a poorly characterized RNA-binding protein (RBP), has an essential role in normal spermatogenesis and sperm function, but whether and how its dysregulation contributing to cancer progression has not yet been explored. Here, we report that STRBP functions as a novel oncogene to drive TNBC progression. STRBP expression was upregulated in TNBC tissues and correlated with poor disease prognosis. Functionally, STRBP promoted TNBC cell proliferation, migration, and invasion in vitro, and enhanced xenograft tumor growth and lung colonization in mice. Mechanistically, STRBP interacted with Dicer, a core component of the microRNA biogenesis machinery, and promoted its proteasomal degradation through enhancing its interaction with E3 ubiquitin ligase UBR5. MicroRNA-sequencing analysis identified miR-200a-3p as a downstream effector of STRBP, which was regulated by Dicer and affected epithelial-mesenchymal transition. Importantly, the impaired malignant phenotypes of TNBC cells caused by STRBP depletion were largely rescued by knockdown of Dicer, and these effects were compromised by transfection of miR-200a-3p mimics. Collectively, these findings revealed a previously unrecognized oncogenic role of STRBP in TNBC progression and identified STRBP as a promising target against TNBC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Breast Surgery, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, 200032, China.
- Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
- Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai, 200032, China; Department of Oncology, Fudan University Shanghai Cancer Center, Shanghai Medical College,…
- Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, China.
- Department of Breast Surgery, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, 200032, China; Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, Sh…
- Department of Breast Surgery, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, 200032, China. Electronic address: liugy688@163.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Chen, S. Y., Zhang, F. L., Zhang, Y. L., Liao, L., Deng, L., Shao, Z. M., Liu, G. Y., & Li, D. Q. (2024). Spermatid perinuclear RNA-binding protein promotes UBR5-mediated proteolysis of Dicer to accelerate triple-negative breast cancer progression. Cancer Letters, 586, 216672. https://doi.org/10.1016/j.canlet.2024.216672
Vancouver
Chen SY, Zhang FL, Zhang YL, Liao L, Deng L, Shao ZM, et al. Spermatid perinuclear RNA-binding protein promotes UBR5-mediated proteolysis of Dicer to accelerate triple-negative breast cancer progression. Cancer Letters. 2024;586:216672. doi:10.1016/j.canlet.2024.216672
BibTeX
@article{Chen2024,
author = {Chen, Si-Yu and Zhang, Fang-Lin and Zhang, Yin-Ling and Liao, Li and Deng, Ling and Shao, Zhi-Min and Liu, Guang-Yu and Li, Da-Qiang},
title = {Spermatid perinuclear RNA-binding protein promotes UBR5-mediated proteolysis of Dicer to accelerate triple-negative breast cancer progression},
journal = {Cancer Letters},
year = {2024},
volume = {586},
pages = {216672},
doi = {10.1016/j.canlet.2024.216672}
}
EUVIMED